Swiss National Bank’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-113,969
| Closed | -$4.74M | – | 2631 |
|
|
2023
Q2 | $4.74M | Buy |
113,969
+1,400
| +1% | +$57.5K | ﹤0.01% | 1350 |
|
|
2023
Q1 | $4.65M | Sell |
112,569
-13,200
| -10% | -$565K | ﹤0.01% | 1325 |
|
|
2022
Q4 | $5.19M | Buy |
125,769
+2,400
| +2% | +$97.2K | ﹤0.01% | 1293 |
|
|
2022
Q3 | $5.41M | Buy |
123,369
+1,100
| +0.9% | +$53.3K | ﹤0.01% | 1234 |
|
|
2022
Q2 | $6.01M | Hold |
122,269
| – | – | ﹤0.01% | 1213 |
|
|
2022
Q1 | $6.93M | Buy |
122,269
+8,200
| +7% | +$436K | ﹤0.01% | 1234 |
|
|
2021
Q4 | $5.99M | Hold |
114,069
| – | – | ﹤0.01% | 1333 |
|
|
2021
Q3 | $6.83M | Buy |
114,069
+800
| +0.7% | +$49.3K | ﹤0.01% | 1242 |
|
|
2021
Q2 | $7.68M | Sell |
113,269
-3,900
| -3% | -$266K | ﹤0.01% | 1186 |
|
|
2021
Q1 | $7.68M | Buy |
117,169
+1,300
| +1% | +$78K | 0.01% | 1175 |
|
|
2020
Q4 | $6.53M | Sell |
115,869
-500
| -0.4% | -$24.6K | ﹤0.01% | 1190 |
|
|
2020
Q3 | $5.65M | Hold |
116,369
| – | – | ﹤0.01% | 1095 |
|
|
2020
Q2 | $6.48M | Buy |
116,369
+15,400
| +15% | +$891K | 0.01% | 999 |
|
|
2020
Q1 | $5.12M | Buy |
100,969
+1,400
| +1% | +$93.9K | 0.01% | 922 |
|
|
2019
Q4 | $7.7M | Buy |
99,569
+1,900
| +2% | +$134K | 0.01% | 896 |
|
|
2019
Q3 | $6.19M | Buy |
97,669
+1,600
| +2% | +$100K | 0.01% | 978 |
|
|
2019
Q2 | $5.62M | Buy |
96,069
+2,400
| +3% | +$142K | 0.01% | 1053 |
|
|
2019
Q1 | $5.32M | Buy |
93,669
+2,700
| +3% | +$144K | 0.01% | 1043 |
|
|
2018
Q4 | $4.51M | Buy |
90,969
+1,600
| +2% | +$96.2K | 0.01% | 1049 |
|
|
2018
Q3 | $6.34M | Buy |
89,369
+1,000
| +1% | +$63.6K | 0.01% | 970 |
|
|
2018
Q2 | $4.61M | Hold |
88,369
| – | – | 0.01% | 1166 |
|
|
2018
Q1 | $4.61M | Buy |
88,369
+1,800
| +2% | +$91.3K | 0.01% | 1095 |
|
|
2017
Q4 | $5.06M | Buy |
86,569
+2,300
| +3% | +$130K | 0.01% | 1050 |
|
|
2017
Q3 | $4.67M | Hold |
84,269
| – | – | 0.01% | 1058 |
|
|
2017
Q2 | $6.48M | Buy |
84,269
+1,200
| +1% | +$89.7K | 0.01% | 848 |
|
|
2017
Q1 | $6.2M | Buy |
83,069
+600
| +0.7% | +$43.5K | 0.01% | 862 |
|
|
2016
Q4 | $5.55M | Buy |
82,469
+2,100
| +3% | +$135K | 0.01% | 888 |
|
|
2016
Q3 | $5.36M | Sell |
80,369
-531
| -0.7% | -$33.8K | 0.01% | 868 |
|
|
2016
Q2 | $4.83M | Buy |
80,900
+1,300
| +2% | +$70.3K | 0.01% | 923 |
|
|
2016
Q1 | $3.74M | Buy |
79,600
+16,100
| +25% | +$731K | 0.01% | 1044 |
|
|
2015
Q4 | $3.44M | Buy |
63,500
+600
| +1% | +$30.6K | 0.01% | 991 |
|
|
2015
Q3 | $3.03M | Buy |
62,900
+8,300
| +15% | +$429K | 0.01% | 1058 |
|
|
2015
Q2 | $2.59M | Buy |
54,600
+1,900
| +4% | +$88.8K | 0.01% | 1149 |
|
|
2015
Q1 | $2.42M | Buy |
52,700
+700
| +1% | +$32.5K | 0.01% | 1167 |
|
|
2014
Q4 | $2.45M | Buy |
52,000
+1,500
| +3% | +$62.5K | 0.01% | 1127 |
|
|
2014
Q3 | $1.76M | Buy |
50,500
+500
| +1% | +$17.8K | 0.01% | 1278 |
|
|
2014
Q2 | $1.78M | Hold |
50,000
| – | – | 0.01% | 1333 |
|
|
2014
Q1 | $1.92M | Buy |
50,000
+10,500
| +27% | +$386K | 0.01% | 1238 |
|
|
2013
Q4 | $1.28M | Buy |
39,500
+1,000
| +3% | +$30K | 0.01% | 1343 |
|
|
2013
Q3 | $943K | Sell |
38,500
-2,000
| -5% | -$49.2K | ﹤0.01% | 1486 |
|
|
2013
Q2 | $1M | Buy |
+40,500
| New | +$886K | ﹤0.01% | 1423 |
|
Other funds holding NUVA
Swiss National Bank's NUVA Position: Q3 2023 in Review
Swiss National Bank sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 113,969 shares — an estimated $4.74M sold.
Swiss National Bank first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $7.7M in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Swiss National Bank reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Swiss National Bank sold 113,969 NuVasive, Inc. shares in Q3 2023, an estimated $4.74M.
- Swiss National Bank first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
- Swiss National Bank's NuVasive, Inc. position peaked at $7.7M in Q4 2019.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Swiss National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.